Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with Lidocaine for IVRA in Upper Limb Surgery
NCT07034300Phase 4Recruiting
- Sponsor
- Fatima Memorial Hospital
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Fatima Memorial Hospital. Primary endpoint: Duration of Postoperative Analgesia at 24 hours. Started May 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07034300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034300.